<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-sub-section" /><meta name="keywords" content="Hypercalcaemia; Sodium chloride: infusion: hypercalcaemia; Bisphosphonates: hypercalcaemia; Corticosteroids: hypercalcaemia; Calcitonin: hypercalcaemia; Hyperparathyroidism; Cinacalcet; Hypercalciuria; Bendroflumethiazide: hypercalciuria" /><meta name="IX" content="Hypercalcaemia; Sodium chloride: infusion: hypercalcaemia; Bisphosphonates: hypercalcaemia; Corticosteroids: hypercalcaemia; Calcitonin: hypercalcaemia; Hyperparathyroidism; Cinacalcet; Hypercalciuria; Bendroflumethiazide: hypercalciuria" /><title>9.5.1.2 Hypercalcaemia and hypercalciuria: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="5049.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="5049.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=5049.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2076.htm">9 Nutrition and blood</a> &gt; <a href="5028.htm">9.5 Minerals</a> &gt; <a href="5029.htm">9.5.1 Calcium and magnesium</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="5031.htm" title="Previous: CALCIUM SALTS">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="129072.htm" title="Next: CINACALCET">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1 id="_5049">9.5.1.2 Hypercalcaemia and hypercalciuria</h1><?highlighter on?><div id="pC" class="jN"><div><div class="cAZ"><h2>Severe hypercalcaemia</h2> <p class="cAX">Severe hypercalcaemia calls for urgent treatment before detailed
investigation of the cause. Dehydration should be corrected first
with intravenous infusion of <b><span>sodium chloride</span> 0.9%</b>. Drugs (such as thiazides and vitamin D compounds)
which promote hypercalcaemia, should be discontinued and dietary calcium
should be restricted.</p><p>If <i>severe hypercalcaemia persists</i> drugs which
inhibit mobilisation of calcium from the skeleton may be required.
The <b>bisphosphonates</b> are useful and <span>disodium
pamidronate</span> (<a title=" Bisphosphonates" href="4446.htm#_4446">section 6.6.2</a>) is probably the most effective.</p><p><b><span>Corticosteroids</span> </b> (<a title=" Corticosteroids" href="4249.htm#_4249">section 6.3</a>) are widely given, but may only be useful where
hypercalcaemia is due to sarcoidosis or vitamin D intoxication; they
often take several days to achieve the desired effect.</p><p><b>Calcitonin</b> (<a title=" Calcitonin" href="4440.htm#_4440">section
6.6.1</a>) is relatively non-toxic but its effect can wear off
after a few days despite continued use; it is rarely effective where
bisphosphonates have failed to reduce serum calcium adequately.</p><p>After treatment of severe hypercalcaemia the underlying cause
must be established. <i>Further treatment</i> is governed
by the same principles as for initial therapy. Salt and water depletion
and drugs promoting hypercalcaemia should be avoided; oral administration
of a bisphosphonate may be useful.</p></div><div class="cAZ"><h2>Hyperparathyroidism</h2> <p class="cAX"><b>Cinacalcet</b> is licensed for the treatment of secondary hyperparathyroidism in
dialysis patients with end-stage renal disease (but see NICE guidance
below), for primary hyperparathyroidism in patients where parathyroidectomy
is inappropriate, and for the treatment of hypercalcaemia in parathyroid
carcinoma. Cinacalcet reduces parathyroid hormone which leads to a
decrease in serum calcium concentrations.</p><p><b>Paricalcitol</b> (<a title="sub-section: Vitamin D" href="5130.htm#_5130">section 9.6.4</a>) is also licensed for the prevention and treatment
of secondary hyperparathyroidism associated with chronic renal failure.</p><p>Parathyroidectomy may be indicated for hyperparathyroidism.</p><div class="cN"><h2 class="cBR">NICE guidance</h2><h3 class="cBP">Cinacalcet for the treatment of secondary hyperparathyroidism
in patients with end-stage renal disease on maintenance dialysis therapy
(January 2007)</h3><p>Cinacalcet is not recommended for the routine treatment of secondary
hyperparathyroidism in patients with end-stage renal disease on maintenance
dialysis therapy.</p><p>Cinacalcet is recommended for the treatment of refractory secondary
hyperparathyroidism in patients with end-stage renal disease (including
those with calciphylaxis) <b>only</b> in those:</p><ul class="cBF"><li><p class="cQ">who have ‘very uncontrolled’ plasma concentration of intact
parathyroid hormone (defined as greater than 85 picomol/litre) refractory
to standard therapy, and a normal or high adjusted serum calcium concentration,<br /><b>and</b></p></li><li><p class="cQ">in whom surgical parathyroidectomy is contraindicated,
in that the risks of surgery outweigh the benefits.</p></li></ul><p>Response to treatment should be monitored regularly and treatment
should be continued only if a reduction in the plasma concentration
of intact parathyroid hormone of 30% or greater is seen within 4 months
of treatment.</p></div></div><div class="cAZ"><h2>Hypercalciuria</h2> <p class="cAX">Hypercalciuria should be investigated for an underlying cause, which
should be treated. Where a cause is not identified (idiopathic hypercalciuria),
the condition is managed by increasing fluid intake and giving <span>bendroflumethiazide</span> in a dose of 2.5 mg daily (a higher
dose is not usually necessary). Reducing dietary calcium intake may
be beneficial but severe restriction of calcium intake has not proved
beneficial and may even be harmful.</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li id="_129072"><a href="129072.htm" title="CINACALCET">CINACALCET</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="5031.htm">Previous: CALCIUM SALTS</a> | <a class="top" href="5049.htm#">Top</a> | <a accesskey="]" href="129072.htm">Next: CINACALCET</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>